Oncology Mergers Are on the Rise. How Can Independent Practices Survive?June 25, 2024DLBCLMixed TopicsPediatricsBusiness of MedicineAggressive LymphomasALLAML
US Hospitals Prone to Cyberattacks Like One That Impacted Patient Care at Ascension, Experts SayJune 21, 2024Business of Medicine
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024DLBCLGene TherapyMixed TopicsBusiness of MedicineAggressive LymphomasALLAML
One Patient Changed This Oncologist’s View of Hope. Here’s How.June 19, 2024Patient & Survivor CareDLBCLMixed TopicsPediatricsAggressive LymphomasALLAML
AMA Wrestles With AI But Acts on Prior Authorization, Other ConcernsJune 14, 2024Business of Medicine
Are Children Born Through ART at Higher Risk for Cancer?June 10, 2024PediatricsDLBCLPatient & Survivor CareAggressive LymphomasALLAMLB Cell Lymphoma
FDA Approves First-in-Class Drug for Lower-Risk Myelodysplastic SyndromesJune 7, 2024Myelodysplastic Syndrome
